Published in Am J Hypertens on April 01, 2007
Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD) | NCT01398943
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA (2013) 5.31
Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2012) 1.79
Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis (2011) 1.23
The effect of oral antioxidants on brachial artery flow-mediated dilation following 5 and 10 min of ischemia. Eur J Appl Physiol (2009) 1.09
Essential hypertension and oxidative stress: New insights. World J Cardiol (2014) 1.04
DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens (2009) 1.04
Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers. Am J Physiol Heart Circ Physiol (2009) 1.02
Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young Black and White women. Nutr J (2008) 0.88
Multicomponent supplement containing Chlorella decreases arterial stiffness in healthy young men. J Clin Biochem Nutr (2013) 0.87
Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry. Vasc Health Risk Manag (2014) 0.86
Human endothelial dysfunction: EDCFs. Pflugers Arch (2010) 0.86
Differential gene expression between wild-type and Gulo-deficient mice supplied with vitamin C. Genet Mol Biol (2011) 0.85
Importance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transport. Biomed Res Int (2014) 0.84
Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Drug Des Devel Ther (2015) 0.84
Effect of muscadine grape seed supplementation on vascular function in subjects with or at risk for cardiovascular disease: a randomized crossover trial. J Am Coll Nutr (2010) 0.84
Impact of sympathetic nervous system activity on post-exercise flow-mediated dilatation in humans. J Physiol (2015) 0.83
Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis. Mol Med (2009) 0.83
Alzheimer's disease and endothelial dysfunction. Neurol Sci (2009) 0.82
Changes in arterial stiffness and nitric oxide production with Chlorella-derived multicomponent supplementation in middle-aged and older individuals. J Clin Biochem Nutr (2015) 0.82
Up Regulation of cystathione γ lyase and Hydrogen Sulphide in the Myocardium Inhibits the Progression of Isoproterenol-Caffeine Induced Left Ventricular Hypertrophy in Wistar Kyoto Rats. PLoS One (2016) 0.81
Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses. Br J Clin Pharmacol (2016) 0.80
Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects. Ther Clin Risk Manag (2016) 0.80
Protective effect of anti-oxidants on endothelial function in young Korean-Asians compared to Caucasians. Med Sci Monit (2012) 0.79
Sesame oil consumption exerts a beneficial effect on endothelial function in hypertensive men. Eur J Prev Cardiol (2012) 0.78
Nutraceutical therapies for atherosclerosis. Nat Rev Cardiol (2016) 0.76
Run for your life: exercise, oxidative stress and the ageing endothelium. J Physiol (2009) 0.76
Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness. Dis Markers (2017) 0.75
Assessments of endothelial function and arterial stiffness are reproducible in patients with COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study. J Nutr Gerontol Geriatr (2016) 0.75
α-Tocopherol Improves Microcirculatory Dysfunction on Fructose Fed Hamsters. PLoS One (2015) 0.75
Vascular effects and safety of supplementation with shark liver oil in middle-aged and elderly males. Exp Ther Med (2015) 0.75
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension (2013) 2.82
The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68
Relationship between wave reflection and renal damage in hypertensive patients: a retrospective analysis. J Hypertens (2013) 1.98
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine. J Hypertens (2015) 1.97
The correct administration of antihypertensive drugs according to the principles of clinical pharmacology. Am J Cardiovasc Drugs (2011) 1.92
Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care (2009) 1.91
Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. Eur Heart J (2012) 1.91
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol (2009) 1.81
Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med (2013) 1.78
Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J (2010) 1.67
Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens (2012) 1.62
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab (2003) 1.61
Endothelium-dependent contractions in hypertension. Br J Pharmacol (2005) 1.59
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49
Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens (2005) 1.49
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation (2009) 1.49
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press (2005) 1.49
Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J Hypertens (2002) 1.48
Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord (2005) 1.48
Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension (2003) 1.48
Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients. Nephron Clin Pract (2005) 1.43
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension (2003) 1.43
Left ventricular diastolic function and carotid artery wall in elderly athletes and sedentary controls. Biomed Pharmacother (2004) 1.42
Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev (2012) 1.42
Effect of mild hyperisulinemia on conduit vessel endothelial function: role of noradrenergic activation. J Hypertens (2012) 1.42
Subcutaneous adipose tissue blood flow and vasomotion in morbidly obese patients: long term effect of gastric bypass surgery. Clin Hemorheol Microcirc (2012) 1.41
Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up. Nephrol Dial Transplant (2011) 1.40
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA (2004) 1.40
Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Hypertension (2008) 1.39
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism. J Hypertens (2008) 1.39
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol (2003) 1.33
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab (2006) 1.29
Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol (2009) 1.27
The eye and the heart. Eur Heart J (2013) 1.18
Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol (2004) 1.17
Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol (2011) 1.16
Sleep loss and hypertension: a systematic review. Curr Pharm Des (2013) 1.15
Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension (2012) 1.15
Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev (2010) 1.11
Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs (2002) 1.11
Sympathetic regulation of vascular function in health and disease. Front Physiol (2012) 1.07
Heart rate variability and left ventricular diastolic function in anorexia nervosa. J Adolesc Health (2003) 1.06
Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol (2012) 1.06
Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol (2006) 1.05
Assessment of carotid stiffness and intima-media thickness from ultrasound data: comparison between two methods. J Ultrasound Med (2010) 1.04
Nutritional status and dietary manipulation in predialysis chronic renal failure patients. J Ren Nutr (2004) 1.02
Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis. Free Radic Biol Med (2010) 1.02
Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens (2008) 1.02
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension (2006) 1.02
A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging (2007) 1.01
Task force on: 'Early markers of atherosclerosis: influence of age and sex'. J Cardiovasc Med (Hagerstown) (2013) 0.98
Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension. Hypertension (2010) 0.97
Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomed Pharmacother (2009) 0.97
Endothelium, aging, and hypertension. Curr Hypertens Rep (2006) 0.97
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. Int J Hypertens (2011) 0.96
Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens (2007) 0.96
Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension (2009) 0.96